Blood tests for Alzheimer's diagnosis are emerging as a promising tool for early detection and monitoring of the disease. These tests aim to identify biomarkers associated with Alzheimer's, such as amyloid-beta and tau proteins, which are indicators of the characteristic plaques and tangles in the brain. Advances in technology have made it possible to measure these proteins with high sensitivity and specificity in the blood. This non-invasive approach offers a more accessible, cost-effective, and less burdensome alternative to traditional methods like cerebrospinal fluid analysis and neuroimaging. Blood tests can aid in early diagnosis, potentially leading to earlier intervention and better management of Alzheimer's disease.

The global Blood Tests for Alzheimer's Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Blood Tests for Alzheimer's Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Blood Tests for Alzheimer's Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Blood Tests for Alzheimer's Diagnosis in Clinical Diagnosis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Blood Tests for Alzheimer's Diagnosis include Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Blood Tests for Alzheimer's Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Tests for Alzheimer's Diagnosis.

The Blood Tests for Alzheimer's Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Tests for Alzheimer's Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Tests for Alzheimer's Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Blood Tests for Alzheimer's Diagnosis Market Report

Report Metric	Details
Report Name	Blood Tests for Alzheimer's Diagnosis Market
Segment by Type	Single Molecule Immunoassay Array Analysis Chemiluminescence Method Fluorescence PCR Method Others
Segment by Application	Clinical Diagnosis Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, KingMed Diagnostics, Hoyotek
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Tests for Alzheimer's Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Blood Tests for Alzheimer's Diagnosis Market report?

Ans: The main players in the Blood Tests for Alzheimer's Diagnosis Market are Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, KingMed Diagnostics, Hoyotek

What are the Application segmentation covered in the Blood Tests for Alzheimer's Diagnosis Market report?

Ans: The Applications covered in the Blood Tests for Alzheimer's Diagnosis Market report are Clinical Diagnosis, Research

What are the Type segmentation covered in the Blood Tests for Alzheimer's Diagnosis Market report?

Ans: The Types covered in the Blood Tests for Alzheimer's Diagnosis Market report are Single Molecule Immunoassay Array Analysis, Chemiluminescence Method, Fluorescence PCR Method, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Single Molecule Immunoassay Array Analysis

1.2.3 Chemiluminescence Method

1.2.4 Fluorescence PCR Method

1.2.5 Others

1.3 Market by Application

1.3.1 Global Blood Tests for Alzheimer's Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Diagnosis

1.3.3 Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Blood Tests for Alzheimer's Diagnosis Market Perspective (2019-2030)

2.2 Global Blood Tests for Alzheimer's Diagnosis Growth Trends by Region

2.2.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Blood Tests for Alzheimer's Diagnosis Historic Market Size by Region (2019-2024)

2.2.3 Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Region (2025-2030)

2.3 Blood Tests for Alzheimer's Diagnosis Market Dynamics

2.3.1 Blood Tests for Alzheimer's Diagnosis Industry Trends

2.3.2 Blood Tests for Alzheimer's Diagnosis Market Drivers

2.3.3 Blood Tests for Alzheimer's Diagnosis Market Challenges

2.3.4 Blood Tests for Alzheimer's Diagnosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Blood Tests for Alzheimer's Diagnosis Players by Revenue

3.1.1 Global Top Blood Tests for Alzheimer's Diagnosis Players by Revenue (2019-2024)

3.1.2 Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Players (2019-2024)

3.2 Global Blood Tests for Alzheimer's Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Blood Tests for Alzheimer's Diagnosis Revenue

3.4 Global Blood Tests for Alzheimer's Diagnosis Market Concentration Ratio

3.4.1 Global Blood Tests for Alzheimer's Diagnosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Tests for Alzheimer's Diagnosis Revenue in 2023

3.5 Global Key Players of Blood Tests for Alzheimer's Diagnosis Head office and Area Served

3.6 Global Key Players of Blood Tests for Alzheimer's Diagnosis, Product and Application

3.7 Global Key Players of Blood Tests for Alzheimer's Diagnosis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Tests for Alzheimer's Diagnosis Breakdown Data by Type

4.1 Global Blood Tests for Alzheimer's Diagnosis Historic Market Size by Type (2019-2024)

4.2 Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Type (2025-2030)

5 Blood Tests for Alzheimer's Diagnosis Breakdown Data by Application

5.1 Global Blood Tests for Alzheimer's Diagnosis Historic Market Size by Application (2019-2024)

5.2 Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Blood Tests for Alzheimer's Diagnosis Market Size (2019-2030)

6.2 North America Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024)

6.4 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Blood Tests for Alzheimer's Diagnosis Market Size (2019-2030)

7.2 Europe Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024)

7.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size (2019-2030)

8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (2019-2024)

8.4 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Blood Tests for Alzheimer's Diagnosis Market Size (2019-2030)

9.2 Latin America Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024)

9.4 Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size (2019-2030)

10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024)

10.4 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Blood Tests for Alzheimer's Diagnosis Introduction

11.1.4 Roche Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Quanterix

11.2.1 Quanterix Company Details

11.2.2 Quanterix Business Overview

11.2.3 Quanterix Blood Tests for Alzheimer's Diagnosis Introduction

11.2.4 Quanterix Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.2.5 Quanterix Recent Development

11.3 Quest Diagnostics

11.3.1 Quest Diagnostics Company Details

11.3.2 Quest Diagnostics Business Overview

11.3.3 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Introduction

11.3.4 Quest Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.3.5 Quest Diagnostics Recent Development

11.4 C₂N Diagnostics

11.4.1 C₂N Diagnostics Company Details

11.4.2 C₂N Diagnostics Business Overview

11.4.3 C₂N Diagnostics Blood Tests for Alzheimer's Diagnosis Introduction

11.4.4 C₂N Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.4.5 C₂N Diagnostics Recent Development

11.5 Fujirebio

11.5.1 Fujirebio Company Details

11.5.2 Fujirebio Business Overview

11.5.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Introduction

11.5.4 Fujirebio Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.5.5 Fujirebio Recent Development

11.6 Diadem

11.6.1 Diadem Company Details

11.6.2 Diadem Business Overview

11.6.3 Diadem Blood Tests for Alzheimer's Diagnosis Introduction

11.6.4 Diadem Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.6.5 Diadem Recent Development

11.7 Labcorp

11.7.1 Labcorp Company Details

11.7.2 Labcorp Business Overview

11.7.3 Labcorp Blood Tests for Alzheimer's Diagnosis Introduction

11.7.4 Labcorp Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.7.5 Labcorp Recent Development

11.8 Neurocode

11.8.1 Neurocode Company Details

11.8.2 Neurocode Business Overview

11.8.3 Neurocode Blood Tests for Alzheimer's Diagnosis Introduction

11.8.4 Neurocode Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.8.5 Neurocode Recent Development

11.9 Cognitact

11.9.1 Cognitact Company Details

11.9.2 Cognitact Business Overview

11.9.3 Cognitact Blood Tests for Alzheimer's Diagnosis Introduction

11.9.4 Cognitact Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.9.5 Cognitact Recent Development

11.10 Vazyme International

11.10.1 Vazyme International Company Details

11.10.2 Vazyme International Business Overview

11.10.3 Vazyme International Blood Tests for Alzheimer's Diagnosis Introduction

11.10.4 Vazyme International Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.10.5 Vazyme International Recent Development

11.11 KingMed Diagnostics

11.11.1 KingMed Diagnostics Company Details

11.11.2 KingMed Diagnostics Business Overview

11.11.3 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Introduction

11.11.4 KingMed Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.11.5 KingMed Diagnostics Recent Development

11.12 Hoyotek

11.12.1 Hoyotek Company Details

11.12.2 Hoyotek Business Overview

11.12.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Introduction

11.12.4 Hoyotek Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

11.12.5 Hoyotek Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Single Molecule Immunoassay Array Analysis

Table 3. Key Players of Chemiluminescence Method

Table 4. Key Players of Fluorescence PCR Method

Table 5. Key Players of Others

Table 6. Global Blood Tests for Alzheimer's Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Blood Tests for Alzheimer's Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Blood Tests for Alzheimer's Diagnosis Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Blood Tests for Alzheimer's Diagnosis Market Share by Region (2019-2024)

Table 10. Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Blood Tests for Alzheimer's Diagnosis Market Share by Region (2025-2030)

Table 12. Blood Tests for Alzheimer's Diagnosis Market Trends

Table 13. Blood Tests for Alzheimer's Diagnosis Market Drivers

Table 14. Blood Tests for Alzheimer's Diagnosis Market Challenges

Table 15. Blood Tests for Alzheimer's Diagnosis Market Restraints

Table 16. Global Blood Tests for Alzheimer's Diagnosis Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Blood Tests for Alzheimer's Diagnosis Market Share by Players (2019-2024)

Table 18. Global Top Blood Tests for Alzheimer's Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Tests for Alzheimer's Diagnosis as of 2023)

Table 19. Ranking of Global Top Blood Tests for Alzheimer's Diagnosis Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Blood Tests for Alzheimer's Diagnosis Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Blood Tests for Alzheimer's Diagnosis, Headquarters and Area Served

Table 22. Global Key Players of Blood Tests for Alzheimer's Diagnosis, Product and Application

Table 23. Global Key Players of Blood Tests for Alzheimer's Diagnosis, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Blood Tests for Alzheimer's Diagnosis Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Type (2019-2024)

Table 27. Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Type (2025-2030)

Table 29. Global Blood Tests for Alzheimer's Diagnosis Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Application (2019-2024)

Table 31. Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Application (2025-2030)

Table 33. North America Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (2025-2030) & (US$ Million)

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Blood Tests for Alzheimer's Diagnosis Product

Table 51. Roche Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Quanterix Company Details

Table 54. Quanterix Business Overview

Table 55. Quanterix Blood Tests for Alzheimer's Diagnosis Product

Table 56. Quanterix Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 57. Quanterix Recent Development

Table 58. Quest Diagnostics Company Details

Table 59. Quest Diagnostics Business Overview

Table 60. Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Product

Table 61. Quest Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 62. Quest Diagnostics Recent Development

Table 63. C₂N Diagnostics Company Details

Table 64. C₂N Diagnostics Business Overview

Table 65. C₂N Diagnostics Blood Tests for Alzheimer's Diagnosis Product

Table 66. C₂N Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 67. C₂N Diagnostics Recent Development

Table 68. Fujirebio Company Details

Table 69. Fujirebio Business Overview

Table 70. Fujirebio Blood Tests for Alzheimer's Diagnosis Product

Table 71. Fujirebio Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 72. Fujirebio Recent Development

Table 73. Diadem Company Details

Table 74. Diadem Business Overview

Table 75. Diadem Blood Tests for Alzheimer's Diagnosis Product

Table 76. Diadem Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 77. Diadem Recent Development

Table 78. Labcorp Company Details

Table 79. Labcorp Business Overview

Table 80. Labcorp Blood Tests for Alzheimer's Diagnosis Product

Table 81. Labcorp Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 82. Labcorp Recent Development

Table 83. Neurocode Company Details

Table 84. Neurocode Business Overview

Table 85. Neurocode Blood Tests for Alzheimer's Diagnosis Product

Table 86. Neurocode Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 87. Neurocode Recent Development

Table 88. Cognitact Company Details

Table 89. Cognitact Business Overview

Table 90. Cognitact Blood Tests for Alzheimer's Diagnosis Product

Table 91. Cognitact Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 92. Cognitact Recent Development

Table 93. Vazyme International Company Details

Table 94. Vazyme International Business Overview

Table 95. Vazyme International Blood Tests for Alzheimer's Diagnosis Product

Table 96. Vazyme International Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 97. Vazyme International Recent Development

Table 98. KingMed Diagnostics Company Details

Table 99. KingMed Diagnostics Business Overview

Table 100. KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Product

Table 101. KingMed Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 102. KingMed Diagnostics Recent Development

Table 103. Hoyotek Company Details

Table 104. Hoyotek Business Overview

Table 105. Hoyotek Blood Tests for Alzheimer's Diagnosis Product

Table 106. Hoyotek Revenue in Blood Tests for Alzheimer's Diagnosis Business (2019-2024) & (US$ Million)

Table 107. Hoyotek Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Blood Tests for Alzheimer's Diagnosis Picture

Figure 2. Global Blood Tests for Alzheimer's Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Blood Tests for Alzheimer's Diagnosis Market Share by Type: 2023 VS 2030

Figure 4. Single Molecule Immunoassay Array Analysis Features

Figure 5. Chemiluminescence Method Features

Figure 6. Fluorescence PCR Method Features

Figure 7. Others Features

Figure 8. Global Blood Tests for Alzheimer's Diagnosis Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Blood Tests for Alzheimer's Diagnosis Market Share by Application: 2023 VS 2030

Figure 10. Clinical Diagnosis Case Studies

Figure 11. Research Case Studies

Figure 12. Blood Tests for Alzheimer's Diagnosis Report Years Considered

Figure 13. Global Blood Tests for Alzheimer's Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Blood Tests for Alzheimer's Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Blood Tests for Alzheimer's Diagnosis Market Share by Region: 2023 VS 2030

Figure 16. Global Blood Tests for Alzheimer's Diagnosis Market Share by Players in 2023

Figure 17. Global Top Blood Tests for Alzheimer's Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Tests for Alzheimer's Diagnosis as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Blood Tests for Alzheimer's Diagnosis Revenue in 2023

Figure 19. North America Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Blood Tests for Alzheimer's Diagnosis Market Share by Country (2019-2030)

Figure 21. United States Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Blood Tests for Alzheimer's Diagnosis Market Share by Country (2019-2030)

Figure 25. Germany Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Share by Region (2019-2030)

Figure 33. China Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Blood Tests for Alzheimer's Diagnosis Market Share by Country (2019-2030)

Figure 41. Mexico Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Share by Country (2019-2030)

Figure 45. Turkey Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 49. Quanterix Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 50. Quest Diagnostics Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 51. C₂N Diagnostics Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 52. Fujirebio Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 53. Diadem Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 54. Labcorp Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 55. Neurocode Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 56. Cognitact Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 57. Vazyme International Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 58. KingMed Diagnostics Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 59. Hoyotek Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions